Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,713 | 35,261 | 58,649 | 13,553 | 5,723 |
| Marketable Securities | 81,588 | 49,083 | 21,362 | 39,914 | 0 |
| Receivables | 22,384 | 10,552 | 12,900 | 9,253 | 8,100 |
| Inventories | 15,991 | 8,148 | 7,169 | 5,970 | 4,893 |
| TOTAL | $155,897 | $104,584 | $101,211 | $70,033 | $20,881 |
| Non-Current Assets | |||||
| PPE Net | 13,889 | 6,818 | 4,974 | 3,256 | 2,328 |
| Investments And Advances | 27,499 | 1,942 | 3,666 | 1,500 | 1,340 |
| Intangibles | 206,308 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,966 | 3,571 | 3,881 | 4,537 | 252 |
| TOTAL | $251,662 | $12,331 | $12,521 | $9,293 | $3,920 |
| Total Assets | $407,559 | $116,915 | $113,732 | $79,326 | $24,801 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 8,921 | 7,686 |
| Accounts payable and accrued liabilities | 5,919 | 4,353 | 2,555 | 4,010 | 3,155 |
| Accrued Expenses | 6,874 | 5,485 | 2,877 | 2,442 | 1,904 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,052 |
| TOTAL | $29,385 | $17,951 | $11,597 | $20,171 | $18,512 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,217 | 10,139 |
| Deferred Revenues | 6,928 | 2,721 | 1,886 | 2,011 | 1,336 |
| Other Non-Current Liabilities | 197,246 | 651 | 237 | 374 | 184,891 |
| TOTAL | $227,755 | $2,550 | $1,478 | $2,258 | $195,456 |
| Total Liabilities | $257,140 | $20,501 | $13,075 | $22,429 | $213,968 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,368 | 27,874 | 25,274 | 20,421 | 19,939 |
| Common Shares | 28 | 26 | 25 | 20 | 2 |
| Retained earnings | -310,177 | -257,347 | -240,821 | -221,797 | -199,327 |
| Other shareholders' equity | -794 | -730 | -769 | -754 | -778 |
| TOTAL | $150,419 | $96,414 | $100,657 | $56,897 | $-189,167 |
| Total Liabilities And Equity | $407,559 | $116,915 | $113,732 | $79,326 | $24,801 |